August 8, 2022 |
*Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen its global marcomms offering with the addition of three strategic associate level hires.
Mohinder Mann joins as Associate Medical Director
With over 20 years’ experience delivering medical strategy for big pharma (including medical roles at Ashfield Health and AstraZeneca), Mohinder’s remit includes the oversight of medical output and ensuring scientific and technical accuracy is applied across all communications.
Mohinder said of his appointment: “It has very much always been my belief that medical-marketing is at the core of successful healthcare brands. I am excited to join Evoke Mind+Matter who are aligned with this as an organisation by endeavouring to bring scientific rigour to every client they work with. Every team member very much believes in this ethos, and it’s been great to see the inclusivity for the role of medical when defining the brand strategy and outputs for our client’s brands.”
Nicole Moores joins as Associate Director, Pharma & Lifesciences
Nicole joins the Evoke Mind+Matter pharma global client services team with more than two decades’ consultancy and agency experience spanning senior roles at 90TEN, and deep experience in diabetes, disease awareness and patient behaviour.
Nicole said of her appointment: “It’s not often you get the chance to join an agency with a genuine passion to make a real difference to patient outcomes. Evoke Mind+Matter is this agency. And this is my passion too. What a great time to join! With the strategy and insights that comes with the new Evoke Mind+Matter I’m very excited to be part of a truly inspiring and talented team that focuses on building strong, lasting client partnerships where we work alongside each other for the greater good of making a difference to patients’ lives.”
Sharron Woods joins as Associate Director, Animal Health
Deeply passionate about the health and welfare of animals, Sharron joins Evoke Mind+Matter following a 15+ year career in animal health pharma that includes roles leading marketing teams Bayer Animal Health (now Elanco). Sharron is also an active committee member of the prestigious Veterinary Marketing Association.
Sharron said of her appointment: “Having worked with the animal health team at Evoke Mind+Matter for many years on the client side, I’ve been consistently impressed with the team’s knowledge, expertise and passion for the health and welfare of animals. I am eager to apply my own experience in the sector and help grow our impressive portfolio of global animal health clients even further.”
Evoke Mind+Matter launched a year ago with a fresh, fearless vision of what healthcare communications could be. It closed 2021 with £6m of new business, 200 percent growth in average client revenue, 60 new hires, investment in a new proprietary tech platform, Gravity, and a unique new proposition to make health more human™ by creating meaningful experiences driven by data and emotion to ultimately change behaviour.
Corrina Safeio, UK MD said of the recent appointments: “Our integrated offering has grown exponentially, and our ‘health first, sector second’ approach means we can deliver full-service capability from deep pharma to disease awareness and public health campaigns right through to animal health. We’re so excited to welcome Mohinder, Sharron and Nicole to our senior team, which reflects our ongoing commitment to recruiting the best talent in the industry to deliver game changing work that really matters for our clients and the patients (and animals!) we serve.”
This content was provided by Inizio
Latest Content from Inizio
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...
Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.
At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...
Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.
